Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

MD Insider Trading

Pediatrix Medical Group, Inc. | Services-Hospitals

Comprehensive Trading Performance Summary

The investment history of corporate insiders at Pediatrix Medical Group, Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Services-Hospitals sector.

Last 7 Days
$0
Buys
$0
Sells
Last 30 Days Trend
$0
Buys
$0
Sells

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2012-02-18 01:00 2012-02-16 SOSA ENRIQUE Director OPT+S $75.07 20,000 $1,501,404 0 0.0%
2012-02-11 01:00 2012-02-09 ALVAREZ CESAR L Director OPT+S $72.21 6,000 $433,260 10,000 0.0%
2012-02-04 00:14 2012-02-03 WALDEMAR, MD CARLO A Director OPT+S $71.70 8,000 $573,600 0 0.0%
2011-11-11 00:01 2011-11-08 WAGNER KARL B Officer - Pres, American Anesthesiology SELL $69.72 25,000 $1,743,013 80,649 -23.7%
2011-09-20 00:16 2011-09-19 MEDEL ROGER MD Director, Officer - Chief Executive Officer OPT+S $64.84 50,000 $3,241,900 374,720 0.0%
2011-08-19 23:17 2011-08-17 ALVAREZ CESAR L Director OPT+S $65.25 30,000 $1,957,611 10,000 0.0%
2011-08-08 15:53 2011-08-04 FERNANDEZ MICHAEL Director BUY $65.53 50,000 $3,276,460 64,091 +354.8%
2011-06-10 23:36 2011-06-10 MILLER FREDERICK V MD Officer - President, Pediatrix Division SELL $69.41 10,168 $705,775 20,781 -32.9%
2011-06-10 23:32 2011-06-01 MILLER FREDERICK V MD Officer - President, Pediatrix Division SELL $73.61 5,833 $429,393 30,949 -15.9%
2011-06-10 23:32 2011-06-08 HAWKINS THOMAS W Officer - SVP, General Counsel and Secy. SELL $69.69 21,286 $1,483,394 61,869 -25.6%
2011-06-03 23:30 2011-06-01 CALABRO JOSEPH M Officer - President and COO SELL $73.65 15,590 $1,148,242 130,000 -10.7%
2011-06-03 23:30 2011-06-02 Clark David A. Officer - COO / Pediatrix Division SELL $73.62 8,188 $602,796 17,235 -32.2%
2011-06-03 23:29 2011-06-02 Lopez-Blanco Vivian Officer - Chief Financial Officer SELL $74.56 465 $34,670 25,104 -1.8%
2011-06-03 23:28 2011-06-02 MILLER FREDERICK V MD Officer - President, Pediatrix Division OPT+S $73.61 5,833 $429,393 30,949 0.0%
2011-05-23 23:15 2011-05-20 Clark David A. Officer - COO / Pediatrix Division OPT+S $75.44 1,200 $90,528 17,528 0.0%
2011-05-19 23:16 2011-05-17 HAWKINS THOMAS W Officer - SVP, General Counsel and Secy. OPT+S $73.69 81,250 $5,987,345 66,404 0.0%
2011-05-06 00:00 2011-05-04 WAGNER KARL B Officer - Pres, American Anesthesiology SELL $72.02 29,852 $2,149,950 83,337 -26.4%
2011-05-05 23:57 2011-05-04 Lopez-Blanco Vivian Officer - Chief Financial Officer SELL $72.00 1,850 $133,200 17,674 -9.5%
2011-05-05 23:54 2011-05-03 MILLER FREDERICK V MD Officer - President, Pediatrix Division OPT+S $72.40 12,500 $905,001 21,681 0.0%
2011-04-29 23:22 2011-04-28 MILLER FREDERICK V MD Officer - President, Pediatrix Division OPT+S $70.44 10,482 $738,345 21,681 0.0%
2011-04-08 23:17 2011-04-06 MILLER FREDERICK V MD Officer - President, Pediatrix Division OPT+S $70.44 1,185 $83,469 21,681 0.0%
2011-03-12 00:03 2011-03-10 WALDEMAR, MD CARLO A Director OPT+S $67.02 8,000 $536,134 0 0.0%
2010-12-11 00:29 2010-12-10 Clark David A. Officer - COO / Pediatrix Division OPT+S $64.75 7,456 $482,769 17,528 0.0%
2010-12-04 00:33 2010-12-02 Clark David A. Officer - COO / Pediatrix Division OPT+S $64.72 2,960 $191,565 17,528 0.0%
2010-11-05 23:16 2010-11-04 Lopez-Blanco Vivian Officer - Chief Financial Officer SELL $61.50 1,850 $113,775 19,395 -8.7%
2010-09-03 23:19 2010-05-07 FREEMAN ROGER K Director SELL $59.00 24,000 $1,416,000 800 -96.8%
2010-09-03 23:15 2010-05-12 WALDEMAR, MD CARLO A Director SELL $60.25 6,000 $361,500 0 -100.0%
2010-06-04 00:22 2010-06-03 CALABRO JOSEPH M Officer - President and COO SELL $58.06 32,019 $1,859,138 111,950 -22.2%
2010-06-04 00:22 2010-06-01 Clark David A. Officer - COO / Pediatrix Division SELL $55.95 6,755 $377,908 9,067 -42.7%
2010-06-04 00:21 2010-06-01 MILLER FREDERICK V MD Officer - President, Pediatrix Division SELL $55.95 8,267 $462,500 11,810 -41.2%
2010-06-04 00:21 2010-06-02 HAWKINS THOMAS W Officer - SVP, General Counsel and Secy. SELL $56.83 16,664 $947,048 67,194 -19.9%
2010-04-05 23:30 2010-04-01 MILLER FREDERICK V MD Officer - President, Pediatrix Division SELL $59.06 10,347 $611,044 20,077 -34.0%
2010-01-06 01:17 2009-12-31 MEDEL ROGER MD Director, Officer - Chief Executive Officer OPT+S $60.45 24,000 $1,450,805 243,825 0.0%
2009-12-31 01:17 2009-12-29 MEDEL ROGER MD Director, Officer - Chief Executive Officer OPT+S $60.88 46,427 $2,826,327 243,825 0.0%
2009-12-29 01:18 2009-12-23 MILLER FREDERICK V MD Officer - President, Pediatrix Division OPT+S $59.83 5,735 $343,119 30,424 0.0%
2009-12-29 01:18 2009-12-23 MEDEL ROGER MD Director, Officer - Chief Executive Officer OPT+S $60.54 57,525 $3,482,667 243,825 0.0%
2009-12-23 01:10 2009-12-21 MILLER FREDERICK V MD Officer - President, Pediatrix Division OPT+S $59.70 1,104 $65,911 30,424 0.0%
2009-12-18 00:52 2009-12-15 MILLER FREDERICK V MD Officer - President, Pediatrix Division OPT+S $59.79 3,786 $226,370 30,424 0.0%
2009-12-09 00:30 2009-12-04 MEDEL ROGER MD Director, Officer - Chief Executive Officer OPT+S $57.09 48,899 $2,791,742 243,825 0.0%
2009-12-04 01:40 2009-12-01 MILLER FREDERICK V MD Officer - President, Pediatrix Division SELL $56.58 2,570 $145,419 30,424 -7.8%
2009-12-04 01:38 2009-12-01 MEDEL ROGER MD Director, Officer - Chief Executive Officer OPT+S $57.06 51,101 $2,915,803 243,825 0.0%
2009-11-13 00:30 2009-11-10 GABOS PAUL G Director OPT+S $56.01 44,000 $2,464,634 0 0.0%
2009-11-05 01:00 2009-11-03 CALABRO JOSEPH M Officer - President and COO SELL $54.70 37,350 $2,043,172 99,391 -27.3%
2009-10-03 00:00 2009-10-01 MILLER FREDERICK V MD Officer - President, Pediatrix Division SELL $54.43 14,007 $762,402 32,994 -29.8%
2009-09-17 00:00 2009-09-14 HAWKINS THOMAS W Officer - SVP, General Counsel and Secy. SELL $52.78 10,000 $527,825 62,450 -13.8%
2009-09-16 00:01 2009-09-11 FERNANDEZ MICHAEL Director SELL $51.56 30,778 $1,586,914 11,160 -73.4%
2009-09-11 00:11 2009-09-08 MEDEL ROGER MD Director, Officer - Chief Executive Officer OPT+S $51.19 40,000 $2,047,672 243,825 0.0%
2009-09-11 00:10 2009-09-08 FERNANDEZ MICHAEL Director SELL $51.25 122,500 $6,277,733 41,938 -74.5%
2009-09-05 00:25 2009-09-02 WAGNER KARL B Officer - Chief Financial Officer SELL $52.02 13,907 $723,421 83,622 -14.3%
2009-09-05 00:25 2009-09-02 MEDEL ROGER MD Director, Officer - Chief Executive Officer OPT+S $51.49 60,000 $3,089,334 243,825 0.0%
SHOW ENTRIES
151-200 OF 245

How to Interpret $MD Trades

Not every insider transaction in Pediatrix Medical Group, Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $MD shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for MD

Insider activity data for Pediatrix Medical Group, Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $MD, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.